With patients demanding experimental drugs, ‘right to try’ is becoming the law of the land

HARRISBURG, Pa. — To hear Bob Godshall tell it, he has no business being alive.

Eleven years ago, at age 72, he was diagnosed with multiple myeloma1, a type of bone cancer. His doctors told him to get his affairs in order. He’d be gone within a year.

But when Godshall learned some myeloma patients bought time with bone marrow transplants, he asked his doctors if he could get one, too. “No way,” they said, citing his advanced age.

Read Full Article Here >>